Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 596

1.

Structure of constituents isolated from the bark of Cassipourea malosana and their cytotoxicity against a human ovarian cell line.

Nishiyama Y, Noda Y, Nakatani N, Shitan N, Sudo T, Kato A, Chalo Mutiso PB.

J Nat Med. 2018 Oct 23. doi: 10.1007/s11418-018-1254-2. [Epub ahead of print]

PMID:
30353358
2.

Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan.

Sudo T, Sato A.

Ther Innov Regul Sci. 2017 Sep;51(5):589-596. doi: 10.1177/2168479017705155. Epub 2017 Apr 18.

PMID:
30231689
3.

Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel.

Seino M, Ohta T, Sugiyama A, Sakaki H, Sudo T, Tsutsumi S, Shigeta S, Tokunaga H, Toyoshima M, Yaegashi N, Nagase S.

Oncotarget. 2018 Aug 10;9(62):31985-31998. doi: 10.18632/oncotarget.25868. eCollection 2018 Aug 10.

4.

Spontaneous colloidal metal network formation driven by molten salt electrolysis.

Natsui S, Sudo T, Kaneko T, Tonya K, Nakajima D, Kikuchi T, Suzuki RO.

Sci Rep. 2018 Aug 30;8(1):13114. doi: 10.1038/s41598-018-31521-3.

5.

A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.

Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Sudo T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.

Cancer Med. 2018 Sep;7(9):4217-4227. doi: 10.1002/cam4.1623. Epub 2018 Jul 26.

6.

FGFRL1 deficiency reduces motility and tumorigenic potential of cells derived from oesophageal squamous cell carcinomas.

Takei Y, Matsumura T, Watanabe K, Nakamine H, Sudo T, Shimizu K, Shimada Y.

Oncol Lett. 2018 Jul;16(1):809-814. doi: 10.3892/ol.2018.8739. Epub 2018 May 18.

7.

Qualitative Study on the Psychological Experiences of Trans-man and Trans-woman.

Sudo T, Yamamoto K, Yoshikawa R.

Tokai J Exp Clin Med. 2018 Jul 20;43(2):45-49.

8.

Variable SATB1 Levels Regulate Hematopoietic Stem Cell Heterogeneity with Distinct Lineage Fate.

Doi Y, Yokota T, Satoh Y, Okuzaki D, Tokunaga M, Ishibashi T, Sudo T, Ueda T, Shingai Y, Ichii M, Tanimura A, Ezoe S, Shibayama H, Kohwi-Shigematsu T, Takeda J, Oritani K, Kanakura Y.

Cell Rep. 2018 Jun 12;23(11):3223-3235. doi: 10.1016/j.celrep.2018.05.042.

9.

Tumor lysis syndrome associated with docetaxel and carboplatin in a case with recurrent endometrial cancer.

Ito T, Ohta T, Narumi M, Sakaki H, Seino M, Sudo T, Nagase S.

Gynecol Oncol Rep. 2018 Feb 24;24:21-23. doi: 10.1016/j.gore.2018.02.005. eCollection 2018 May.

10.

Antibacterial, Hydrophilic Effect and Mechanical Properties of Orthodontic Resin Coated with UV-Responsive Photocatalyst.

Kuroiwa A, Nomura Y, Ochiai T, Sudo T, Nomoto R, Hayakawa T, Kanzaki H, Nakamura Y, Hanada N.

Materials (Basel). 2018 May 25;11(6). pii: E889. doi: 10.3390/ma11060889.

11.

Transformed Follicular Lymphoma (TFL) Predicts Outcome in Advanced Endometrial Cancer.

Wakahashi S, Kawakami F, Wakahashi K, Minagawa K, Matsuo K, Katayama Y, Yamada H, Matsui T, Sudo T.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):963-969. doi: 10.1158/1055-9965.EPI-17-0762. Epub 2018 May 21.

PMID:
29784731
12.

Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy.

Fujino S, Kinugasa T, Sudo T, Mizobe T, Yoshida T, Yoshida N, Ohchi T, Tajiri K, Yuge K, Nagasu S, Katagiri M, Akagi Y.

Oncol Rep. 2018 Jul;40(1):101-110. doi: 10.3892/or.2018.6407. Epub 2018 Apr 30.

PMID:
29750310
13.

The HNF-1β-USP28-Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma.

Ito F, Yoshimoto C, Yamada Y, Sudo T, Kobayashi H.

Oncotarget. 2018 Apr 3;9(25):17512-17522. doi: 10.18632/oncotarget.24776. eCollection 2018 Apr 3.

14.

Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01).

Hagiwara Y, Ohashi Y, Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T; JASPAC 01 Study Group.

Eur J Cancer. 2018 Apr;93:79-88. doi: 10.1016/j.ejca.2018.01.081. Epub 2018 Mar 20.

PMID:
29477795
15.

Cell death in neural precursor cells and neurons before neurite formation prevents the emergence of abnormal neural structures in the Drosophila optic lobe.

Hara Y, Sudo T, Togane Y, Akagawa H, Tsujimura H.

Dev Biol. 2018 Apr 1;436(1):28-41. doi: 10.1016/j.ydbio.2018.02.004. Epub 2018 Feb 12.

PMID:
29447906
16.

Aneurysm of the inferior vena cava with thrombosis.

Inoue M, Sudo T, Yamaguchi M, Seo S, Miyamoto T, Misumi T, Shimizu W, Irei T, Suzuki T, Onoe T, Shimizu Y, Hinoi T, Tashiro H.

Clin Case Rep. 2018 Jan 13;6(2):402-406. doi: 10.1002/ccr3.1321. eCollection 2018 Feb.

17.

Malignancy during pregnancy in Japan: an exceptional opportunity for early diagnosis.

Sekine M, Kobayashi Y, Tabata T, Sudo T, Nishimura R, Matsuo K, Grubbs BH, Enomoto T, Ikeda T.

BMC Pregnancy Childbirth. 2018 Feb 8;18(1):50. doi: 10.1186/s12884-018-1678-4.

18.

[Dynamic analysis of hematopoietic stem cells in the bone marrow by intravital imaging.]

Sudo T, Mizuno H.

Clin Calcium. 2018;28(2):231-236. doi: CliCa1802231236. Japanese.

PMID:
29371489
19.

[A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer].

Miyamoto T, Inoue M, Tanemura M, Yamaguchi M, Irei T, Tamaru K, Seo S, Misumi T, Shimizu W, Suzuki T, Onoe T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2018 Jan;45(1):88-90. Japanese.

PMID:
29362317
20.

Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis.

Ishibashi T, Yokota T, Satoh Y, Ichii M, Sudo T, Doi Y, Ueda T, Nagate Y, Hamanaka Y, Tanimura A, Ezoe S, Shibayama H, Oritani K, Kanakura Y.

Biochem Biophys Res Commun. 2018 Jan 15;495(3):2338-2343. doi: 10.1016/j.bbrc.2017.12.117. Epub 2017 Dec 22.

PMID:
29274779
21.

Variants at HLA-A, HLA-C, and HLA-DQB1 Confer Risk of Psoriasis Vulgaris in Japanese.

Hirata J, Hirota T, Ozeki T, Kanai M, Sudo T, Tanaka T, Hizawa N, Nakagawa H, Sato S, Mushiroda T, Saeki H, Tamari M, Okada Y.

J Invest Dermatol. 2018 Mar;138(3):542-548. doi: 10.1016/j.jid.2017.10.001. Epub 2017 Oct 12.

22.

Effect of extracellular electron shuttles on arsenic-mobilizing activities in soil microbial communities.

Yamamura S, Sudo T, Watanabe M, Tsuboi S, Soda S, Ike M, Amachi S.

J Hazard Mater. 2018 Jan 15;342:571-578. doi: 10.1016/j.jhazmat.2017.08.071. Epub 2017 Sep 1.

PMID:
28888188
23.

Insulin-producing cells derived from 'induced pluripotent stem cells' of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genes.

Hosokawa Y, Toyoda T, Fukui K, Baden MY, Funato M, Kondo Y, Sudo T, Iwahashi H, Kishida M, Okada C, Watanabe A, Asaka I, Osafune K, Imagawa A, Shimomura I.

J Diabetes Investig. 2017 Aug 10. doi: 10.1111/jdi.12727. [Epub ahead of print]

24.

Non-labeling multiphoton excitation microscopy as a novel diagnostic tool for discriminating normal tissue and colorectal cancer lesions.

Matsui T, Mizuno H, Sudo T, Kikuta J, Haraguchi N, Ikeda JI, Mizushima T, Yamamoto H, Morii E, Mori M, Ishii M.

Sci Rep. 2017 Jul 31;7(1):6959. doi: 10.1038/s41598-017-07244-2.

25.

Significance of CD47 expression in gastric cancer.

Sudo T, Takahashi Y, Sawada G, Uchi R, Mimori K, Akagi Y.

Oncol Lett. 2017 Jul;14(1):801-809. doi: 10.3892/ol.2017.6257. Epub 2017 May 26.

26.

Association of NOD2 Mutations with Aggressive Periodontitis.

Sudo T, Okada Y, Ozaki K, Urayama K, Kanai M, Kobayashi H, Gokyu M, Izumi Y, Tanaka T.

J Dent Res. 2017 Sep;96(10):1100-1105. doi: 10.1177/0022034517715432. Epub 2017 Jul 6.

PMID:
28682159
27.

Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells.

Kondo Y, Toyoda T, Ito R, Funato M, Hosokawa Y, Matsui S, Sudo T, Nakamura M, Okada C, Zhuang X, Watanabe A, Ohta A, Inagaki N, Osafune K.

Diabetologia. 2017 Aug;60(8):1454-1466. doi: 10.1007/s00125-017-4302-7. Epub 2017 May 22.

PMID:
28534195
28.

A human PSMB11 variant affects thymoproteasome processing and CD8+ T cell production.

Ohigashi I, Ohte Y, Setoh K, Nakase H, Maekawa A, Kiyonari H, Hamazaki Y, Sekai M, Sudo T, Tabara Y, Sawai H, Omae Y, Yuliwulandari R, Tanaka Y, Mizokami M, Inoue H, Kasahara M, Minato N, Tokunaga K, Tanaka K, Matsuda F, Murata S, Takahama Y.

JCI Insight. 2017 May 18;2(10). pii: 93664. doi: 10.1172/jci.insight.93664. [Epub ahead of print]

29.

Prognostic impact of normalization of serum tumor markers following neoadjuvant chemotherapy in patients with borderline resectable pancreatic carcinoma with arterial contact.

Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Nakagawa N, Okada K, Takahashi S, Sueda T.

Cancer Chemother Pharmacol. 2017 Apr;79(4):801-811. doi: 10.1007/s00280-017-3281-1. Epub 2017 Mar 17.

PMID:
28314992
30.

A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma.

Kondo N, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakagawa N, Takahashi S, Ohge H, Sueda T.

Cancer Chemother Pharmacol. 2017 Apr;79(4):775-781. doi: 10.1007/s00280-017-3274-0. Epub 2017 Mar 14.

PMID:
28293715
31.

Genetic and Pharmacological Inhibition of p38α Improves Locomotor Recovery after Spinal Cord Injury.

Umezawa H, Naito Y, Tanaka K, Yoshioka K, Suzuki K, Sudo T, Hagihara M, Hatano M, Tatsumi K, Kasuya Y.

Front Pharmacol. 2017 Feb 17;8:72. doi: 10.3389/fphar.2017.00072. eCollection 2017.

32.

RpA1 ameliorates symptoms of mutant ataxin-1 knock-in mice and enhances DNA damage repair.

Taniguchi JB, Kondo K, Fujita K, Chen X, Homma H, Sudo T, Mao Y, Watase K, Tanaka T, Tagawa K, Tamura T, Muramatsu SI, Okazawa H.

Hum Mol Genet. 2016 Oct 15;25(20):4432-4447. doi: 10.1093/hmg/ddw272.

PMID:
28173122
33.

Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.

Sudo T, Nishida R, Kawahara A, Saisho K, Mimori K, Yamada A, Mizoguchi A, Kadoya K, Matono S, Mori N, Tanaka T, Akagi Y.

Ann Surg Oncol. 2017 Nov;24(12):3763-3770. doi: 10.1245/s10434-017-5796-4. Epub 2017 Feb 3.

PMID:
28160141
34.

[A Case of Ovarian Cancer with Lymph Node Metastasis in the Lesser Curvature of the Stomach Resected Using Laparoscopic Surgery].

Tanaka K, Jeongho M, Hatanaka N, Inoue M, Miyamoto T, Yamaguchi M, Seo S, Misumi T, Shimizu W, Irei T, Suzuki T, Onoe T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2380-2382. Japanese.

PMID:
28133328
35.

[A Case of Angiomyolipoma Occurring in the Mesentery of the Transverse Colon and Treated Using Laparoscopic Excision].

Inoue M, Tanemura M, Hatanaka N, Miyamoto T, Seo S, Yamaguchi M, Misumi T, Shimizu W, Irei T, Onoe T, Suzuki T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2271-2273. Japanese.

PMID:
28133292
36.

[A Case of Myxofibrosarcoma of the Retroperitoneum].

Inoue M, Yamaguchi M, Kohada Y, Jeongho M, Hatanaka N, Seo S, Misumi T, Shimizu W, Irei T, Suzuki T, Onoe T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2109-2111. Review. Japanese.

PMID:
28133238
37.

Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact.

Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Nakagawa N, Takahashi S, Sueda T.

Cancer Chemother Pharmacol. 2017 Jan;79(1):37-47. doi: 10.1007/s00280-016-3199-z. Epub 2016 Nov 22.

PMID:
27878355
38.

Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells.

Matsumura S, Ohta T, Yamanouchi K, Liu Z, Sudo T, Kojimahara T, Seino M, Narumi M, Tsutsumi S, Takahashi T, Takahashi K, Kurachi H, Nagase S.

Cancer Biol Ther. 2017 Sep 2;18(9):730-739. doi: 10.1080/15384047.2016.1235656. Epub 2016 Sep 30.

39.

Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal Cancer.

Shiraiwa S, Kinugasa T, Kawahara A, Mizobe T, Ohchi T, Yuge K, Fujino S, Katagiri M, Shimomura S, Tajiri K, Sudo T, Kage M, Kuwano M, Akagi Y.

Anticancer Res. 2016 Jul;36(7):3781-8.

PMID:
27354655
40.

The Selective Arterial Calcium Injection Test is a Valid Diagnostic Method for Invisible Gastrinoma with Duodenal Ulcer Stenosis: A Case Report.

Okada K, Sudo T, Miyamoto K, Yokoyama Y, Sakashita Y, Hashimoto Y, Kobayashi H, Otsuka H, Sakoda T, Shimamoto F.

Hiroshima J Med Sci. 2016 Mar;65(1):13-7.

PMID:
27348901
41.

[The Effectiveness of Epidural Droperidol for Prophylaxis of Postoperative Nausea and Vomiting: A Comparative Study of Droperidol and Adrenaline].

Toyonaga S, Shinozuka N, Dobashi T, Iiyori N, Sudo T.

Masui. 2016 May;65(5):516-21. Japanese.

PMID:
27319097
42.

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).

Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y; JASPAC 01 Study Group.

Lancet. 2016 Jul 16;388(10041):248-57. doi: 10.1016/S0140-6736(16)30583-9. Epub 2016 Jun 2.

PMID:
27265347
43.

Diagnosis of desmoplastic small-round-cell tumor by cytogenetic analysis: a case report.

Wakahashi S, Sudo T, Ichida K, Sugita S, Hasegawa T, Nagao S, Yamaguchi S, Sakuma T, Yamada H.

Clin Case Rep. 2016 Apr 15;4(5):520-3. doi: 10.1002/ccr3.558. eCollection 2016 May.

44.

Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.

Sudo T, Yokota T, Okuzaki D, Ueda T, Ichii M, Ishibashi T, Isono T, Habuchi Y, Oritani K, Kanakura Y.

PLoS One. 2016 Apr 25;11(4):e0154189. doi: 10.1371/journal.pone.0154189. eCollection 2016.

45.

Interactive evolutionary computation with minimum fitness evaluation requirement and offline algorithm design.

Ishibuchi H, Sudo T, Nojima Y.

Springerplus. 2016 Feb 27;5:192. doi: 10.1186/s40064-016-1789-1. eCollection 2016.

46.

A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.

Morimoto A, Nagao S, Kogiku A, Yamamoto K, Miwa M, Wakahashi S, Ichida K, Sudo T, Yamaguchi S, Fujiwara K.

Jpn J Clin Oncol. 2016 Jun;46(6):517-21. doi: 10.1093/jjco/hyw029. Epub 2016 Mar 13.

PMID:
26977055
47.

Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.

Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, Shiraishi Y, Chiba K, Imoto S, Takahashi Y, Iwaya T, Sudo T, Hayashi T, Takai H, Kawasaki Y, Matsukawa T, Eguchi H, Sugimachi K, Tanaka F, Suzuki H, Yamamoto K, Ishii H, Shimizu M, Yamazaki H, Yamazaki M, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Mafune K, Tanaka Y, Kelsell DP, Scott CA, Tsuji S, Yachida S, Shibata T, Sugano S, Doki Y, Akiyama T, Aburatani H, Ogawa S, Miyano S, Mori M, Mimori K.

Gastroenterology. 2016 May;150(5):1171-1182. doi: 10.1053/j.gastro.2016.01.035. Epub 2016 Feb 10.

48.

ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.

Ishibashi T, Yokota T, Tanaka H, Ichii M, Sudo T, Satoh Y, Doi Y, Ueda T, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y.

Exp Hematol. 2016 Apr;44(4):269-81.e1. doi: 10.1016/j.exphem.2015.12.010. Epub 2016 Jan 14.

PMID:
26774386
49.

Maladaptive change of body representation in the brain after damage to central or peripheral nervous system.

Oouchida Y, Sudo T, Inamura T, Tanaka N, Ohki Y, Izumi S.

Neurosci Res. 2016 Mar;104:38-43. doi: 10.1016/j.neures.2015.12.015. Epub 2015 Dec 31. Review.

PMID:
26748075
50.

Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy.

Okano K, Murakami Y, Nakagawa N, Uemura K, Sudo T, Hashimoto Y, Kondo N, Takahashi S, Sueda T.

Surgery. 2016 Mar;159(3):885-92. doi: 10.1016/j.surg.2015.08.046. Epub 2015 Oct 23.

PMID:
26603844

Supplemental Content

Support Center